Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA rec…

Biotechnology

US, Boston [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

PRAX M&As
Biotechnology M&A

M&A Deals · Breakdown

Praxis Precision Medicines, Inc. has no acquisition track records yet.

M&A Deals · History

Praxis Precision Medicines, Inc. has no acquisition track records yet.